To investigate the selective inhibitory effect of gracillin, we evaluated the effect of gracillin on the activation of P‐STAT3, P‐STAT1, P‐STAT4 and P‐STAT5 in CRC cells. Here, STAT1 is linked to colorectal carcinoma.